Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Chemical Hazard Early-Detection Program Seeks ‘Potential’ Risk Data

This article was originally published in The Tan Sheet

Executive Summary

In a contract solicitation, FDA’s Center for Food Safety and Applied Nutrition offers insight into its developing “early warning” system for potential chemical hazards in supplements, foods and cosmetics. The agency seeks a contractor to mine data and identify potential risks based on hazard “signals” across a spectrum of information sources.

You may also be interested in...

Supplement Adverse Event Reports Sprout In Fertile Field Of Social Media

Compliance with FDA regulations on supplement marketers reporting serious adverse events means scrutinizing all information about a product on social media pages the same way a firm would comments that consumers or other parties submit by using contact information on product labeling.

FDA Proposes Early Detection System For CFSAN-Regulated Products

CFSAN says the program would involve a center-wide, coordinated and systematic effort to identify and then move signals about contaminants, through a review, management and follow-up process. The process could result in an early response by FDA and other agencies to potentially hazardous chemical threats.

Supplement Ingredient Suppliers Should Prepare For Food HACCP Regs

The exemption Congress gave dietary supplement manufacturers from the hazard analysis and critical control points regulations for food products does not extend to ingredient suppliers, experts say.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts